<a href=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-3... Demidenko</a>: Scholar in Oncology Science
<a href=https://www.instagram.com/hibou_sova/>Zoya Demidenko</a> is a prominent scholar associated with the Department of Cell Stress Research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Previously, she conducted research at the NIH and New York Medical College, establishing a robust background in biomedical study.
Her scholarly contributions spans a number of critical fields, encompassing the PI3K/AKT/mTOR signaling pathway, cell cycle management, cellular aging, and tumor biology. Currently, she has authored over 46 scientific papers, which have received upwards of 4,100 mentions — a indicator to the influence of her work.
One of her most notable discoveries lies in explaining the mechanisms of cell aging. Her research revealed that when the cell cycle is arrested but cellular growth proceeds, the cells experience senescence. Crucially, <a href=https://moodylab.smhs.gwu.edu/lab-members>Zoya Demidenko</a> showed that this process is pharmacologically suppressed using agents such as rapamycin.
<a href=https://www.facebook.com/public/Zoya-Demidenko/>Zoya Demidenko</a> has additionally contributed considerably to cancer treatment investigation, particularly in the area of cyclotherapy — a method aimed at shielding healthy tissue from anticancer drugs while leaving cancer cells vulnerable. This approach holds significant potential for diminishing the side effects of cancer treatment.
Across her professional journey, Demidenko has worked with top researchers globally, including Dr. Mikhail Blagosklonny. Her publications can be found in top-tier periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, <a href=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.002612... Demidenko</a> stands as a influential figure in current oncological research, whose findings keep to guide our understanding of the way cells grow old, respond to therapy, and the ways in which cancer might be better targeted. https://www.oncotarget.com/article/4836/
Zoya Demidenko https://pubmed.ncbi.nlm.nih.gov/22228887/
<a href=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-3... Demidenko</a>: Scholar in Oncology Science
<a href=https://www.instagram.com/hibou_sova/>Zoya Demidenko</a> is a prominent scholar associated with the Department of Cell Stress Research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Previously, she conducted research at the NIH and New York Medical College, establishing a robust background in biomedical study.
Her scholarly contributions spans a number of critical fields, encompassing the PI3K/AKT/mTOR signaling pathway, cell cycle management, cellular aging, and tumor biology. Currently, she has authored over 46 scientific papers, which have received upwards of 4,100 mentions — a indicator to the influence of her work.
One of her most notable discoveries lies in explaining the mechanisms of cell aging. Her research revealed that when the cell cycle is arrested but cellular growth proceeds, the cells experience senescence. Crucially, <a href=https://moodylab.smhs.gwu.edu/lab-members>Zoya Demidenko</a> showed that this process is pharmacologically suppressed using agents such as rapamycin.
<a href=https://www.facebook.com/public/Zoya-Demidenko/>Zoya Demidenko</a> has additionally contributed considerably to cancer treatment investigation, particularly in the area of cyclotherapy — a method aimed at shielding healthy tissue from anticancer drugs while leaving cancer cells vulnerable. This approach holds significant potential for diminishing the side effects of cancer treatment.
Across her professional journey, Demidenko has worked with top researchers globally, including Dr. Mikhail Blagosklonny. Her publications can be found in top-tier periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, <a href=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.002612... Demidenko</a> stands as a influential figure in current oncological research, whose findings keep to guide our understanding of the way cells grow old, respond to therapy, and the ways in which cancer might be better targeted.
https://www.oncotarget.com/article/4836/